Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus.

Diegelmann J, Beigel F, Zitzmann K, Kaul A, Göke B, Auernhammer CJ, Bartenschlager R, Diepolder HM, Brand S.

PLoS One. 2010 Dec 8;5(12):e15200. doi: 10.1371/journal.pone.0015200.

2.

SOCS-1 inhibits expression of the antiviral proteins 2',5'-OAS and MxA induced by the novel interferon-lambdas IL-28A and IL-29.

Brand S, Zitzmann K, Dambacher J, Beigel F, Olszak T, Vlotides G, Eichhorst ST, Göke B, Diepolder H, Auernhammer CJ.

Biochem Biophys Res Commun. 2005 Jun 3;331(2):543-8.

PMID:
15850793
3.

Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication.

Zhu H, Butera M, Nelson DR, Liu C.

Virol J. 2005 Sep 7;2:80.

4.

Transcriptional regulation of IFN-λ genes in hepatitis C virus-infected hepatocytes via IRF-3·IRF-7·NF-κB complex.

Lee HC, Narayanan S, Park SJ, Seong SY, Hahn YS.

J Biol Chem. 2014 Feb 21;289(8):5310-9. doi: 10.1074/jbc.M113.536102. Epub 2014 Jan 2. Erratum in: J Biol Chem. 2014 Apr 25;289(17):11861.

5.

Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics.

Marcello T, Grakoui A, Barba-Spaeth G, Machlin ES, Kotenko SV, MacDonald MR, Rice CM.

Gastroenterology. 2006 Dec;131(6):1887-98. Epub 2006 Oct 1.

PMID:
17087946
6.

IFN-Alpha receptor-1 upregulation in PBMC from HCV naïve patients carrying cc genotype. possible role of IFN-lambda.

Lalle E, Bordi L, Caglioti C, Garbuglia AR, Castilletti C, Taibi C, Cristofari F, Capobianchi MR.

PLoS One. 2014 Apr 1;9(4):e93434. doi: 10.1371/journal.pone.0093434. eCollection 2014.

7.

Interferon-lambda serum levels in hepatitis C.

Langhans B, Kupfer B, Braunschweiger I, Arndt S, Schulte W, Nischalke HD, Nattermann J, Oldenburg J, Sauerbruch T, Spengler U.

J Hepatol. 2011 May;54(5):859-65. doi: 10.1016/j.jhep.2010.08.020. Epub 2010 Oct 23.

PMID:
21145813
8.

IFN-λ Inhibits MiR-122 Transcription through a Stat3-HNF4α Inflammatory Feedback Loop in an IFN-α Resistant HCV Cell Culture System.

Aboulnasr F, Hazari S, Nayak S, Chandra PK, Panigrahi R, Ferraris P, Chava S, Kurt R, Song K, Dash A, Balart LA, Garry RF, Wu T, Dash S.

PLoS One. 2015 Dec 11;10(12):e0141655. doi: 10.1371/journal.pone.0141655. eCollection 2015.

9.
10.

Human blood dendritic cell antigen 3 (BDCA3)(+) dendritic cells are a potent producer of interferon-λ in response to hepatitis C virus.

Yoshio S, Kanto T, Kuroda S, Matsubara T, Higashitani K, Kakita N, Ishida H, Hiramatsu N, Nagano H, Sugiyama M, Murata K, Fukuhara T, Matsuura Y, Hayashi N, Mizokami M, Takehara T.

Hepatology. 2013 May;57(5):1705-15. doi: 10.1002/hep.26182. Epub 2013 Mar 14.

PMID:
23213063
11.

DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.

Grünvogel O, Esser-Nobis K, Reustle A, Schult P, Müller B, Metz P, Trippler M, Windisch MP, Frese M, Binder M, Fackler O, Bartenschlager R, Ruggieri A, Lohmann V.

J Virol. 2015 Oct;89(20):10548-68. doi: 10.1128/JVI.01297-15. Epub 2015 Aug 12.

12.

Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes.

Doyle SE, Schreckhise H, Khuu-Duong K, Henderson K, Rosler R, Storey H, Yao L, Liu H, Barahmand-pour F, Sivakumar P, Chan C, Birks C, Foster D, Clegg CH, Wietzke-Braun P, Mihm S, Klucher KM.

Hepatology. 2006 Oct;44(4):896-906.

PMID:
17006906
13.

Type III interferons, IL-28 and IL-29, are increased in chronic HCV infection and induce myeloid dendritic cell-mediated FoxP3+ regulatory T cells.

Dolganiuc A, Kodys K, Marshall C, Saha B, Zhang S, Bala S, Szabo G.

PLoS One. 2012;7(10):e44915. doi: 10.1371/journal.pone.0044915. Epub 2012 Oct 10.

14.

IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression.

Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, Otte JM, Diebold J, Diepolder H, Adler B, Auernhammer CJ, Göke B, Dambacher J.

Am J Physiol Gastrointest Liver Physiol. 2005 Nov;289(5):G960-8. Epub 2005 Jul 28.

15.

Human type 2 myeloid dendritic cells produce interferon-λ and amplify interferon-α in response to hepatitis C virus infection.

Zhang S, Kodys K, Li K, Szabo G.

Gastroenterology. 2013 Feb;144(2):414-425.e7. doi: 10.1053/j.gastro.2012.10.034. Epub 2012 Oct 23.

16.

Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.

Nandakumar R, Finsterbusch K, Lipps C, Neumann B, Grashoff M, Nair S, Hochnadel I, Lienenklaus S, Wappler I, Steinmann E, Hauser H, Pietschmann T, Kröger A.

Gastroenterology. 2013 Dec;145(6):1414-23.e1. doi: 10.1053/j.gastro.2013.08.037. Epub 2013 Aug 21.

PMID:
23973921
17.

EPSTI1 Is Involved in IL-28A-Mediated Inhibition of HCV Infection.

Meng X, Yang D, Yu R, Zhu H.

Mediators Inflamm. 2015;2015:716315. doi: 10.1155/2015/716315. Epub 2015 Jun 3.

18.

Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons.

Laidlaw SM, Marukian S, Gilmore RH, Cashman SB, Nechyporuk-Zloy V, Rice CM, Dustin LB.

Gastroenterology. 2017 Aug;153(2):566-578.e5. doi: 10.1053/j.gastro.2017.04.021. Epub 2017 Apr 26.

19.

Interleukin-29 suppresses hepatitis A and C viral internal ribosomal entry site-mediated translation.

Kanda T, Wu S, Kiyohara T, Nakamoto S, Jiang X, Miyamura T, Imazeki F, Ishii K, Wakita T, Yokosuka O.

Viral Immunol. 2012 Oct;25(5):379-86. doi: 10.1089/vim.2012.0021.

PMID:
23035851
20.

STAT3 induces anti-hepatitis C viral activity in liver cells.

Zhu H, Shang X, Terada N, Liu C.

Biochem Biophys Res Commun. 2004 Nov 12;324(2):518-28.

PMID:
15474458

Supplemental Content

Support Center